B
Bradley C. Martin
Researcher at University of Arkansas for Medical Sciences
Publications - 145
Citations - 8830
Bradley C. Martin is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Population & Medicaid. The author has an hindex of 41, co-authored 133 publications receiving 7777 citations. Previous affiliations of Bradley C. Martin include University of Arkansas & University of Georgia.
Papers
More filters
Journal ArticleDOI
Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015
TL;DR: In this paper, patient records from the IMS Lifelink+ database were analyzed to characterize the first episode of opioid use among commercially insured, opioid-naive, cancer-free adults and quantify the increase in probability of long-term use of opioids with each additional day supplied, day of therapy, or incremental increase in cumulative dose.
Journal ArticleDOI
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
TL;DR: This study provided an initial empirical basis for selecting 0.80 as a reasonable cut-off point that stratifies adherent and non-adherent patients based on predicting subsequent hospitalization across several highly prevalent chronic diseases.
Journal ArticleDOI
Smartphone medication adherence apps: Potential benefits to patients and providers
TL;DR: Despite being untested, medication apps represent a possible strategy that pharmacists can recommend to nonadherent patients and incorporate into their practice.
Journal ArticleDOI
The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.
Mark J. Edlund,Bradley C. Martin,Joan Russo,Andrea DeVries,Jennifer Brennan Braden,Mark Sullivan +5 more
TL;DR: Patients with CNCP prescribed opioids had significantly higher rates of OUDs compared with those not prescribed opioids, and duration of opioid therapy was more important than daily dose in determining OUD risk.
Journal ArticleDOI
Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.
Mark D. Sullivan,Mark J. Edlund,Ming Yu Fan,Andrea DeVries,Jennifer Brennan Braden,Bradley C. Martin +5 more
TL;DR: Trends in opioid therapy for NCPC in two disparate populations, one national and commercially insured population (HealthCore plan data) and one state‐based and publicly‐insured population over a six year period (2000–2005), likely represent a broad‐based shift in opioid treatment philosophy.